NASDAQ: IRLA
Irulya Therapeutics Inc Stock Ownership - Who owns Irulya Therapeutics?

Insider buying vs selling

Have Irulya Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Luca BenattiDirector2025-12-2650,000$3.47
$173.50kSell
Brendan HannahCBO COO CCO2025-12-052,271$0.55
$1.25kBuy
Brendan HannahCBO COO CCO2025-12-0525,280$0.94
$23.76kBuy

1 of 1

IRLA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when IRLA insiders and whales buy or sell their stock.

IRLA Shareholders

What type of owners hold Irulya Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Epiq Capital Group LLC2,237.13%22,753,059$737.20MInsider
David Lamond431.05%4,384,096$142.04MInsider
Pierre Lamond283.81%2,886,530$93.52MInsider
Pfizer Inc283.17%2,879,973$93.31MInsider
Takeda Ventures Inc263.48%2,679,802$86.83MInsider
Stephen S. Dominy141.36%1,437,674$46.58MInsider
Casey Lynch116.08%1,180,580$38.25MInsider
Dirk Thye97.82%994,885$32.23MInsider
Philip S. Low51.06%519,283$16.82MInsider
Brendan Hannah35.58%361,827$11.72MInsider

1 of 3

IRLA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
IRLA0.00%100.00%Net Selling
RNAZ0.00%22.26%
NXTC0.01%99.99%Net BuyingNet Buying
EDSA0.04%99.96%Net Buying
IGC0.01%24.61%Net Buying

Irulya Therapeutics Stock Ownership FAQ

Who owns Irulya Therapeutics?

Irulya Therapeutics (NASDAQ: IRLA) is owned by 0.03% institutional shareholders, 4,050.93% Irulya Therapeutics insiders, and 0.00% retail investors. Epiq Capital Group LLC is the largest individual Irulya Therapeutics shareholder, owning 22.75M shares representing 2,237.13% of the company. Epiq Capital Group LLC's Irulya Therapeutics shares are currently valued at $634.13M.

If you're new to stock investing, here's how to buy Irulya Therapeutics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.